As of May 2024 Bellerophon Therapeutics has a market cap of $0.62 Million. This makes Bellerophon Therapeutics the world's 8367th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.62 M | 38.65% |
2023 | $0.45 M | -94.73% |
2022 | $8.59 M | -70.85% |
2021 | $29.46 M | -53.48% |
2020 | $63.35 M | 163.69% |
2019 | $24.02 M | -48.91% |
2018 | $47.02 M | -66.97% |
2017 | $0.14 B | 763.25% |
2016 | $16.49 M | -57.57% |
2015 | $38.86 M |
On May 1st, 2024 the market cap of Bellerophon Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | $183.56 B | 29,251,513.47% | ๐บ๐ธ USA |
Baxter BAX | $19.04 B | 3,034,292.78% | ๐บ๐ธ USA |
Lantheus Holdings LNTH | $5.24 B | 836,396.18% | ๐บ๐ธ USA |
Abeona Therapeutics
ABEO | $0.10 B | 16,682.56% | ๐บ๐ธ USA |